BSX BOSTON SCIENTIFIC CORP

NEUTRAL Impact: 3/10 Insider Cluster (3 insiders)
Horizon days Filed May 21, 2026 Processed 22d 16h ago
Insider cluster: 2 insiders, $329K total
Latest settled — T+5d ⚠ clustered
BSX ▼ -16.96% at T+5d
NEUTRAL call ✗ call lost -16.96% · α vs SPY -18.62% · entry $57.71 → $47.92
Next anchor: T+20d in 9d
Currently $46.91 · -18.71% from $57.71 entry
Entry anchored
May 21, 2026
via day open
T+1d
-0.15%
call -0.15% · α -0.74%
$57.62
settled 22d ago
T+5d
-16.96%
call -16.96% · α -18.62%
$47.92
settled 15d ago
T+20d
call — · α —
in 9d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a cluster of insider buying is generally a bullish signal, the absolute dollar amount is only ~0.0007% of BSX's $84.2B market cap, rendering it economically trivial. Historical calibration data for this ticker shows past reports have produced negative T+20 outcomes and the calibration cell for this impact level has a low observed probability of up-moves, suggesting this cluster is noise rather than a meaningful signal.

Key Financial Metrics

Direction
buying
Total Value
$554.0K
Insiders
3

Actionable Insight

Ignore this cluster. The dollar value is immaterial relative to company size, no C-suite participation, and historical model reads on BSX have been net negative at T+20. No directional trading signal.

Key Facts

  • Three directors (Ludwig, Pegus, Habiger) purchased shares on May 19-20, 2026.
  • Total open-market purchase value: ~$554K across 4 trades.
  • Market cap: $84.2B — purchases represent ~0.0007% of market cap, well below the 0.1% materiality threshold.
  • No C-suite executives participated; all buyers are independent directors.
  • All trades were open-market (code P) — no 10b5-1 plans noted.
  • Historical calibration for this ticker shows past reports have significantly underperformed; model score-6/7 cells on BSX have sub-35% up-move probability at T+20.

Financial Impact

Approximately $554K in aggregate insider purchases against an $84.2B market cap — economically insignificant.

buybacksinsider ownership

Risk Factors

  • Past model performance on BSX is poor — do not extrapolate from historical calibration to current filing.
  • Director purchases this small are likely personal allocation decisions, not informed trading.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (41 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BSX-1779398497301
5 reports for BSX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BSX — sortable, filterable
Type Now
May 21, 2026
22d ago
Insider Cluster
NEUTRAL ★ 3/10
$57.71 $47.92▼ −16.96%▼ −18.62%$46.91 (−18.71%)
May 18, 2026
26d ago
8-K
NEUTRAL ★ 4/10
$55.89 $57.62▲ +3.10%▲ +1.48%$46.91 (−16.06%)
May 18, 2026
26d ago
8-K
BULLISH ★ 7/10
$55.89 $57.62▲ +3.10%▲ +1.48%$46.91 (−16.06%)
Mar 18, 2026
12w ago
DEFA14A
NEUTRAL ★ 3/10
$69.88 $70.14▲ +0.37%▲ +2.58%$46.91 (−32.87%)
Feb 28, 2026
15w ago
Institutional Cluster
BULLISH ★ 7/10
$76.13 $71.89▼ −5.57%▼ −4.36%$46.91 (−38.38%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (47h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access